Januvia, the new diabetes drug that features on the diabetes.co.uk drugs to watch list, is set to begin making money for its creator. The Drug maker Merck and Co. had Januvia approved for use in Mexico, the first country to allow sale of the drug to the public.
The powerful Food and Drug Administration (FDA) has a drug application on file for Januvia, and they are expected to make a decision by mid-October. Merck are also filing marketing applications with regulatory authorities in other countries.
Januvia is likely to be the first drug to be approved in a class called dipeptidyl peptidase-4 inhibitors. These drugs serve to enhance the body’s ability to lower rising blood sugar.
Shares in Merck rose by 16 cents up to $41 in afternoon trading at the New York Stock Exchange .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…